CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Electric Acoustic Speech Processor: Electric-acoustic stimulation fitting +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03379870
NCT03379870N/ACompleted

Outcomes in Children With Cochlear Implants and Pre-Operative Residual Hearing: Electric Only and Electric-Acoustic Stimulation

University of North Carolina, Chapel Hill·interventional·Posted Dec 20, 2017·Updated Oct 15, 2024

In Brief

A clinical study evaluating Electric Acoustic Speech Processor: Electric-acoustic stimulation fitting and Electric Acoustic Speech Processor: Full-electric stimulation fitting for High Frequency Sensorineural Hearing Impairment and Hearing Disorders in Children. Completed, enrolled 28 participants across 1 site.

Detailed Summary

Purpose: Routine clinical care and pilot study data has shown evidence of postoperative hearing preservation in pediatric cochlear implant (CI) recipients. The primary aim of this study is to investigate speech perception performance in pediatric CI recipients with functional pre-operative hearing. Participants: Two cohorts of CI recipients aged 6 through 17 years who had pre-operative low frequency residual hearing. Subjects in Arm 1 (EAS Arm; electric-acoustic stimulation) will present with a post-operative low frequency pure tone average (125, 250, and 500 Hz) of ≤ 75 dB HL, and those in Arm 2 (FES Arm; full-electric stimulation) will present with a post-operative low frequency pure tone average (LFPTA) that exceeds 75 dB HL. Procedures (methods): Subjects will complete speech perception and quality of life testing during post-operative intervals. Subjects in the EAS Arm will be evaluated with combined electric-acoustic stimulation (EAS). Subjects in FES Arm will be evaluated with FES alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMed-El Corporation

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 20, 2017
Enrollment StartMay 25, 2018
Primary CompletionDec 14, 2023
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 8.5 years ago

Interventions

Electric Acoustic Speech Processor: Electric-acoustic stimulation fittingdevice

Electric Acoustic Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or better,

Electric Acoustic Speech Processor: Full-electric stimulation fittingdevice

Electric Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or poorer and pre-operative low frequency hearing averages of 75 dB HL or better.